Phase II trial of AKT inhibitor MK-2206 in patients with advanced breast cancer who have tumors with PIK3CA or AKT mutations, and/or PTEN loss/PTEN mutation
| Image |  |
|---|---|
| Description | scientific article published on 05 July 2019 |
| Author/s |
author: Q88437209 Emily Tarco Yisheng Li Ana Maria Gonzalez-Angulo Sarina Piha-Paul Gerburg M Wulf Nancy U Lin Eric Winer Gordon B. Mills |
| Publication date | July 5, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |